Literature DB >> 18796725

In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination.

Rennos Fragkoudis1, Catherine M Ballany1, Amanda Boyd1, John K Fazakerley1.   

Abstract

Semliki Forest virus (SFV) infection of the laboratory mouse provides a well-characterized tractable system to study the pathogenesis of virus encephalitis and virus induced demyelination. In microMT mice, which have no antibodies, infectious virus persisted in both the serum and the brain for several weeks, indicating that antibodies are required to eliminate infectious virus. In immunocompetent mice, virus infectivity in the brain was undetectable after the first week of infection, but virus RNA levels declined slowly. Following SFV infection, lesions of demyelination were present in the brains of both immunocompetent and microMT mice, indicating that antibodies are not required to generate lesions of demyelination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796725     DOI: 10.1099/vir.0.2008/002238-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis.

Authors:  Cristina P Marques; Parul Kapil; David R Hinton; Claudia Hindinger; Stephen L Nutt; Richard M Ransohoff; Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

3.  Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

Review 4.  Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Authors:  Irena Slavuljica; Daria Kveštak; Peter Csaba Huszthy; Kate Kosmac; William J Britt; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

5.  Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.

Authors:  Jeffrey R Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

6.  Small RNA responses of Culex mosquitoes and cell lines during acute and persistent virus infection.

Authors:  Claudia Rückert; Abhishek N Prasad; Selene M Garcia-Luna; Alexis Robison; Nathan D Grubaugh; James Weger-Lucarelli; Gregory D Ebel
Journal:  Insect Biochem Mol Biol       Date:  2019-04-05       Impact factor: 4.714

7.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

Review 8.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

Review 9.  Intrathecal humoral immunity to encephalitic RNA viruses.

Authors:  Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Viruses       Date:  2013-02-15       Impact factor: 5.048

10.  Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus.

Authors:  Manohar B Mutnal; Shuxian Hu; James R Lokensgard
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.